LIVE FREE OR DIE LEGAL
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.

SB289: (New Title) relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.

Bill status: Signed by Governor

Citation
2022 SB289
Official source

Bill details

Version history, amendments, and roll-call votes were not present in the imported local bill data.

House status
Passed/Adopted with Amendment
Senate status
Concurred
Committee
House Health, Human Services and Elderly Affairs
Hearing
04/14/2026 at 09:40 AM
Selected version
Current official bill text

Sponsors

Topics

Health care

Official links

CHAPTER 215

SB 289 - FINAL VERSION

21Apr2022... 1336h

2022 SESSION

22-2984

05/11

SENATE BILL 289

AN ACT relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.

SPONSORS: Sen. Sherman, Dist 24; Sen. Rosenwald, Dist 13; Sen. Bradley, Dist 3; Sen. Watters, Dist 4; Sen. Carson, Dist 14; Sen. Gray, Dist 6; Sen. D'Allesandro, Dist 20; Sen. Ward, Dist 8; Sen. Prentiss, Dist 5; Sen. Cavanaugh, Dist 16; Rep. Merchant, Sull. 4; Rep. Murphy, Graf. 12; Rep. Woods, Merr. 23; Rep. Knirk, Carr. 3; Rep. Marsh, Carr. 8

COMMITTEE: Health and Human Services

AMENDED ANALYSIS

This bill changes a statutory reference from glucagon injections to glucagon administration. This bill also adds a requirement to the dispenser report under the controlled drug prescription health and safety program.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

21Apr2022... 1336h 22-2984

05/11

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty Two

AN ACT relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.

Be it Enacted by the Senate and House of Representatives in General Court convened:

215:1 Glucagon Administration. Amend the section heading of RSA 200:40-b to read as follows:

200:40-b Glucagon [Injections] Administration.

215:2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:

(p) The format of the prescription: electronic, faxed, written, oral, or other.

215:3 Effective Date.

I. Section 1 of this act shall take effect 60 days after its passage.

II. The remainder of this act shall take effect upon its passage.

Approved: June 17, 2022

Effective Date:

I. Section 1 effective August 16, 2022

II. Remainder effective June 17, 2022